natgillin/translations-raw huggingface dataset:
Letifend indeholder det aktive stof protein Q, der er fremstillet af forskellige fragmenter af proteiner fra Leishmania infantum.
Letifend contains the active substance protein Q, which is made of different fragments of proteins from Leishmania infantum.
Hvilke risici er der forbundet med Letifend?
What are the risks associated with Letifend?
Andre oplysninger om Letifend
Other information about Letifend?
Letifend leishmaniasis-vaccine til hunde (rekombinant protein)
Letifend canine leishmaniasis vaccine (recombinant protein)
Når Letifend gives til hunde, opfatter deres immunsystem Leishmania-proteinet som "fremmed" og producerer antistoffer mod det.
When Letifend is given to dogs the immune system recognises the Leishmania protein as ‘foreign' and makes defences against it.
Hundene blev eksponeret for naturlig infektion med Leishmania infantum.
The dogs were exposed to natural infection with Leishmania infantum.
Letifend fås som frysetørret pulver (lyofilisat) og solvens, der klargøres til en suspension til injektion.
Letifend is available as a freeze-dried powder (lyophilisate) and solvent that are made up into a solution for injection, and can only be obtained with a prescription.
Letifend er et veterinærlægemiddel, der anvendes til hunde for at beskytte dem mod leishmaniasis forårsaget af parasitten Leishmania infantum.
Letifend is a veterinary vaccine used in dogs to protect them against leishmaniasis due to the parasite Leishmania infantum.
Vaccinationen bør gentages hvert år med injektion af en enkelt "boosterdosis" for at opretholde
A ‘booster' injection should be given every year to maintain the vaccine's effect.
Før vaccinationen skal hundene testes for Leishmania-infektion.
Before vaccination, dogs should be tested for Leishmania infection.
Hvilke fordele viser undersøgelserne, at der er ved Letifend?
What benefits of Letifend have been shown in studies?
Hvordan anvendes Letifend?
How is Letifend used?
Hvis du som ejer eller ansvarlig for dyret ønsker yderligere oplysninger om behandling med Letifend, kan du læse indlægssedlen eller kontakte din dyrlæge eller dit apotek.
For more information about treatment with Letifend, animal owners or keepers should read the package leaflet or contact their veterinarian or pharmacist.
Hvis du som ejer eller ansvarlig for dyret ønsker praktisk vejledning om anvendelsen af Letifend, kan du læse indlægssedlen eller kontakte din dyrlæge eller dit apotek.
For practical information about using Letifend, animal owners or keepers should read the package leaflet or contact their veterinarian or pharmacist.
Hvordan virker Letifend?
How does Letifend work?
Der bør træffes foranstaltninger for at reducere vaccinerede hundes eksponering for sandfluer, da vaccinen ikke forhindrer Leishmania-infektion.
vaccinated dogs since the vaccine does not prevent Leishmania infection.
Hyppigheder er defineret som meget almindelig (≥1/10), almindelig (≥1/100 til <1/10), ikke almindelig (≥1/1.000 til <1/100), sjælden (≥1/10.000 til <1/1.000), meget sjælden (<1/10.000) eller ikke kendt (kan ikke estimeres ud fra forhåndenværende data).
Frequencies are defined as very common (≥1/10), common (≥1/100 to <1/10), uncommon (≥1/1,000 to <1/100), rare (≥1/10,000 to <1/1,000), very rare (<1/10,000) and not known (cannot be estimated from available data).
BILAG II A. FREMSTILLER (E) ANSVARLIG(E) FOR BATCHFRIGIVELSE B. BETINGELSER ELLER BEGRÆNSNINGER VEDRØRENDE UDLEVERING OG ANVENDELSE C. ANDRE FORHOLD OG BETINGELSER FOR MARKEDSFØRINGSTILLADELSEN D. BETINGELSER ELLER BEGRÆNSNINGER MED HENSYN TIL SIKKER OG EFFEKTIV ANVENDELSE AF LÆGEMIDLET
ANNEX II A. MANUFACTURER(S) RESPONSIBLE FOR BATCH RELEASE B. CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE C. OTHER CONDITIONS AND REQUIREMENTS OF THE MARKETING AUTHORISATION D. CONDITIONS OR RESTRICTIONS WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL PRODUCT
84 tabletter
84 tablets
Patienter med amenorré i uge 13
Patients in amenorrhea at week 13
Patienter med kontrolleret blødningb,c,d
Patients with controlled bleedingb,c, d
Den observerede frekvens svarer til kontrolgrupper og den almindelige forekomst, der er rapporteret i litteraturen for symptomatiske præmenopausale kvinder i denne aldersgruppe (gennemsnitsalder på 40 år).
The observed frequency is in line with control groups and prevalence reported in literature for symptomatic pre-menopausal women of this age group (mean of 40 years).
Før lægemiddelproduktet lanceres i hvert medlemsland, skal indehaveren af markedsføringstilladelsen aftale informationsmaterialets indhold og format med medlemsstatens kompetente myndighed.
Prior to launch of the medicinal product in each Member State, the Marketing Authorisation Holder (MAH) shall agree the content and format of the educational material with the national competent authority.
LÆGEMIDDELFORM OG ANTAL (PAKNINGSSTØRRELSE) 28 tabletter
PHARMACEUTICAL FORM AND CONTENTS 28 tablets
EU/1/18/1309/001 28 tabletter EU/1/18/1309/002 84 tabletter EU/1/18/1309/003 30 tabletter EU/1/18/1309/004 28 tabletter EU/1/18/1309/005 84 tabletter
EU/1/18/1309/001 28 tablets EU/1/18/1309/002 84 tablets EU/1/18/1309/003 30 tablets EU/1/18/1309/004 28 tablets EU/1/18/1309/005 84 tablets
17, rue de Pontoise F-95520 Osny Frankrig
17, rue de Pontoise F-95520 Osny France
Ulipristal Acetate Gedeon Richter bør ikke anvendes til børn under 18 år, da ulipristalacetats sikkerhed og virkning ikke er klarlagt for denne aldersgruppe.
Ulipristal Acetate Gedeon Richter should not be taken by children under 18 years of age since safety and efficacy of ulipristal acetate has not been established in this age group.
Behandling under graviditet kan påvirke graviditeten (det vides ikke, om Ulipristal Acetate Gedeon Richter kan skade barnet, eller om det kan forårsage abort).
Treatment whilst pregnant might affect your pregnancy (it is not known if Ulipristal Acetate Gedeon Richter might harm your baby or whether can cause miscarriage).
Ulipristal Acetate Gedeon Richter anvendes til voksne kvinder (over 18 år), før de kommer i overgangsalderen.
Ulipristal Acetate Gedeon Richter is used in adult women (over 18 years of age) before they reach the menopause.
Fortæl det til lægen eller på apoteket, hvis du tager nogen af de lægemidler, der er nævnt herunder, eftersom disse lægemidler kan påvirke Ulipristal Acetate Gedeon Richter eller blive påvirket af Ulipristal Acetate Gedeon Richter: - Visse lægemidler mod hjertesygdomme (f.eks. digoxin).
Tell your doctor or pharmacist if you are taking any of the medicines listed below, as these medicines can affect Ulipristal Acetate Gedeon Richter or be affected by Ulipristal Acetate Gedeon Richter: - Certain medicines which are used to treat the heart (e.g. digoxin).
FREMSTILLER(E) ANSVARLIG(E) FOR BATCHFRIGIVELSE
A. MANUFACTURER(S) RESPONSIBLE FOR BATCH RELEASE
Din menstruation bør normalt vende tilbage i løbet af 4 uger, efter behandling med Ulipristal Acetate Gedeon Richter er stoppet.
Your period should generally return within 4 weeks after treatment with Ulipristal Acetate Gedeon Richter is stopped.
• informer patienterne om ikke at tage Ulipristal Acetate Gedeon Richter i tilfælde af leverproblemer.
• inform the patients not to take Ulipristal Acetate Gedeon Richter in case of liver problems.
Du skal altid starte med at tage Ulipristal Acetate Gedeon Richter i løbet af menstruationens første uge.
You should always start taking Ulipristal Acetate Gedeon Richter within the first week of your menstrual period.
• behovet for at informere patologen om, at patienter er behandlet med Ulipristal Acetate Gedeon Richter, hvis biopsier/kirurgiske prøver sendes til analyse.
• the need to inform the pathologist that patients were treated with Ulipristal Acetate Gedeon Richter if biopsy/surgical samples are to be sent for analysis.
Du må ikke tage Ulipristal Acetate Gedeon Richter, hvis du er gravid.
Do not take Ulipristal Acetate Gedeon Richter if you are pregnant.
• Ulipristal Acetate Gedeon Richters vigtigste virkninger på PAEC (progesteron-receptormodulator-associerede endometriske ændringer), og hvordan de adskiller sig fra virkningerne af østrogen alene.
• key effects of Ulipristal Acetate Gedeon Richter on Progesterone Receptor Modulator Associated Endometrial Changes (PAEC) and how they differ from those of unopposed oestrogen.
Hvis du har glemt at tage Ulipristal Acetate Gedeon Richter Hvis du glemmer at tage en dosis i mindre end 12 timer, skal du tage den hurtigst muligt.
If you forget to take Ulipristal Acetate Gedeon Richter If you miss a dose by less than 12 hours, take it as soon as you remember.
Behandling med Ulipristal Acetate Gedeon Richter skal iværksættes og overvåges af læger med erfaring i diagnosticering og behandling af uterusfibromer.
Ulipristal Acetate Gedeon Richter treatment is to be initiated and supervised by physicians experienced in the diagnosis and treatment of uterine fibroids.
Ulipristal Acetate Gedeon Richter anvendes enten før operation af dine fibromer eller til langvarig behandling af dine fibromer for at reducere deres størrelse, for at stoppe eller reducere blødning og for at øge antallet af røde blodlegemer.
It is used either before an operation of your fibroids or for long term treatment of your fibroids to reduce their size, to stop or reduce bleeding and to increase your red blood cell count.
Hvis du bliver gravid, mens du er i behandling med Ulipristal Acetate Gedeon Richter, skal du straks holde op med at tage Ulipristal Acetate Gedeon Richter og kontakte din læge eller apoteket.
If you do become pregnant during Ulipristal Acetate Gedeon Richter treatment, you should stop taking Ulipristal Acetate Gedeon Richter immediately and contact your doctor or pharmacist.
Behandling med Ulipristal Acetate Gedeon Richter medfører normalt en væsentlig reduktion eller stopper måske også din menstruation i løbet af de første 10 dages behandling.
Treatment with Ulipristal Acetate Gedeon Richter usually leads to a significant reduction or may even stop your menstrual bleeding (your ‘period') within the first 10 days of treatment.
- Hvis du i øjeblikket anvender hormonprævention (f.eks. p-piller) (se ”Brug af anden medicin sammen med Ulipristal Acetate Gedeon Richter), bør du også bruge en anden pålidelig barriereprævention (f.eks. et kondom), mens du tager Ulipristal Acetate Gedeon Richter.
- If you are currently taking hormonal contraception (for example birth control pills) (see “Other medicines and Ulipristal Acetate Gedeon Richter”) you should use an alternative reliable barrier contraceptive method (such as a condom) while taking Ulipristal Acetate Gedeon Richter.
• informer patienterne om potentielle bivirkninger vedrørende leveren, som kan skyldes Ulipristal Acetate Gedeon Richter.
• inform the patients about potential adverse reactions related to liver that could be caused by the use of Ulipristal Acetate Gedeon Richter.
Før du påbegynder behandling med Ulipristal Acetate Gedeon Richter, bliver der taget blodprøver for at finde ud af, hvor godt din lever fungerer.
Before you start treatment with Ulipristal Acetate Gedeon Richter blood tests will be undertaken to find out how well your liver is working.
Hvis du har fået ordineret flere 3-måneders behandlingsforløb med Ulipristal Acetate Gedeon Richter, må du tidligst starte hvert forløb i den anden menstruationsperiode efter afslutning af det foregående behandlingsforløb.
If you have been prescribed several courses of Ulipristal Acetate Gedeon Richter 3-month treatment, you should start each course at the earliest during the second menstrual period following the previous treatment completion.
Patienter i amenorréb,c
Patients in amenorrheab,c
Det Europæiske Lægemiddelagentur har dispenseret fra kravet om at fremlægge resultaterne af studier med Ulipristal Acetate Gedeon Richter i alle undergrupper af den pædiatriske population med uterusfibromer (se pkt.
The European Medicines Agency has waived the obligation to submit the results of studies with Ulipristal Acetate Gedeon Richter in all subsets of the paediatric population in leiomyoma of uterus (see section 4.2 for information on paediatric use).
KVALITATIV OG KVANTITATIV SAMMENSÆTNING Hver tablet indeholder 5 mg ulipristalacetat.
QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 5 mg of ulipristal acetate.
Ulipristal Acetate Gedeon Richter kan give bivirkninger, men ikke alle får bivirkninger.
Ulipristal Acetate Gedeon Richter can cause side effects although not everybody gets them.
- Hvis du har en lever- eller nyresygdom, skal du fortælle det til lægen eller på apoteket, før du tager Ulipristal Acetate Gedeon Richter.
- If you have liver or kidney disease tell your doctor or pharmacist before taking Ulipristal Acetate Gedeon Richter.
I NEDENSTÅENDE SKEMA KAN DU HOLDE ØJE MED DINE BLODPRØVER: DATO
THE TABLE BELOW HELPS YOU TO TRACK YOUR BLOOD TESTS:
Hvis du holder op med at tage Ulipristal Acetate Gedeon Richter Ulipristal Acetate Gedeon Richter skal tages dagligt i behandlingsforløb på op til 3 måneder uden afbrydelse.
If you stop taking Ulipristal Acetate Gedeon Richter Ulipristal Acetate Gedeon Richter is to be taken daily during treatment courses of up to 3 months continuously.
Under behandlingen med Ulipristal Acetate Gedeon Richter tager din læge jævnligt blodprøver for at kontrollere din leverfunktion.
During treatment with Ulipristal Acetate Gedeon Richter, your doctor will carry out regular blood tests to check your liver function.
I studie 4 var 61,9 % og 72,7 % af patienterne i amenorré ved udløb af både behandlingsforløb 1 og 2 kombineret (doser på hhv. 5 mg og 10 mg, p=0,032), 48,7 % og 60,5 % var i amenorré ved udløb af alle 4 behandlingsforløb kombineret (henholdsvis 5 mg dosis og 10 mg dosis, p=0,027).
In study 4, 61.9% and 72.7% of patients were in amenorrhea at the end of both treatment course 1 and 2 combined (5 mg dose and 10 mg dose, respectively, p=0.032); 48.7 % and 60.5 % were in amenorrhea at the end of all four treatment courses combined (5 mg dose and 10 mg dose,
Derfor frarådes brug af hormonelle præventionsmidler, og du bør bruge en anden pålidelig barriereprævention (f.eks. et kondom), når du er i behandling med Ulipristal Acetate Gedeon Richter.
Therefore, hormonal contraceptives are not recommended and you should use an alternative reliable barrier contraceptive method, such as a condom, during Ulipristal Acetate Gedeon Richter treatment.
Tag ikke Ulipristal Acetate Gedeon Richter - hvis du er allergisk over for ulipristalacetat eller et af de øvrige indholdsstoffer (angivet i pkt.
Do not take Ulipristal Acetate Gedeon Richter - if you are allergic to ulipristal acetate or any of the other ingredients of Ulipristal Acetate
Desuden vil hormonelle præventionsmidler (f.eks. norethindron eller levonorgestrel) også sandsynligvis nedsætte virkningen af Ulipristal Acetate Gedeon Richter.
In addition, hormonal contraceptives and progestagens (e.g. norethindrone or levonorgestrel) are also likely to make Ulipristal Acetate Gedeon Richter less effective.
Brug af anden medicin sammen med Ulipristal Acetate Gedeon Richter Fortæl altid lægen eller på apoteket, hvis du tager anden medicin eller har gjort det for nylig.
Other medicines and Ulipristal Acetate Gedeon Richter Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.
SÆRLIGE OPBEVARINGSBETINGELSER Blistert opbevares i den ydre karton for at beskytte mod lys.
SPECIAL STORAGE CONDITIONS Keep the blisters in the outer carton in order to protect from light.
Ulipristal Acetate Gedeon Richter vil sandsynligvis nedsætte virkningen af visse hormonelle præventionsmidler.
Ulipristal Acetate Gedeon Richter is likely to make some hormonal contraceptives less effective.
Ulipristal Acetate Gedeon Richter vil sandsynligvis nedsætte virkningen af visse hormonelle præventionsmidler (se ”Brug af anden medicin sammen med Ulipristal Acetate Gedeon Richter).
Ulipristal Acetate Gedeon Richter is likely to make some hormonal contraceptives less effective (see “Other medicines and Ulipristal Acetate Gedeon Richter”).
Livmoderslimhinden kan blive tykkere eller ændre sig, når du tager Ulipristal Acetate Gedeon Richter.
The lining of the uterus may thicken or change as a result of taking Ulipristal Acetate Gedeon Richter.
Alt efter resultatet af disse prøver beslutter din læge, om behandling med Ulipristal Acetate Gedeon Richter er egnet til dig.
Depending on the result of these tests your doctor will decide if treatment with Ulipristal Acetate Gedeon Richter is suitable for you.
Hvis du har taget for meget Ulipristal Acetate Gedeon Richter Der er begrænset erfaring med Ulipristal Acetate Gedeon Richter, når der tages flere doser på én gang.
If you take more Ulipristal Acetate Gedeon Richter than you should Experience with Ulipristal Acetate Gedeon Richter when several doses are taken at once is limited.
- Hvis du lider af svær astma, er behandling med Ulipristal Acetate Gedeon Richter måske ikke egnet til dig.
- If you suffer from severe asthma, treatment with Ulipristal Acetate Gedeon Richter may not be suitable for you.
Ulipristal Acetate Gedeon Richter er en hvid til næsten hvid, rund, buet tablet på 7 mm præget med koden ”ES5” på den ene side.
What Ulipristal Acetate Gedeon Richter looks like and contents of the pack Ulipristal Acetate Gedeon Richter is white to off-white, round curved tablet of 7 mm engraved with code “ES5” on one face.
Ikke desto mindre skal du spørge lægen eller apoteket til råds, hvis du tager for meget Ulipristal Acetate Gedeon Richter.
You should nonetheless ask your doctor or pharmacist for advice if you take more Ulipristal Acetate Gedeon Richter than you should.
Du må derfor ikke amme dit barn, når du tager Ulipristal Acetate Gedeon Richter.
Therefore, do not breast-feed your baby while taking Ulipristal Acetate Gedeon Richter.
Ulipristal Acetate Gedeon Richter går over i mælken.
Ulipristal Acetate Gedeon Richter passes into the breast milk.
Alt efter resultatet af blodprøverne vil lægen beslutte, om behandling med Ulipristal Acetate Gedeon Richter er egnet til dig.
Depending on the result of these tests, the doctor will decide if treatment with Ulipristal Acetate Gedeon Richter is suitable for you.
Ulipristal Acetate Gedeon Richter indeholder det aktive stof ulipristalacetat.
Ulipristal Acetate Gedeon Richter contains the active substance ulipristal acetate.
ANGIVELSE AF AKTIVT STOF/AKTIVE STOFFER Hver tablet indeholder 5 mg ulipristalacetat.
STATEMENT OF ACTIVE SUBSTANCE(S) Each tablet contains 5 mg of ulipristal acetate.
INFORMATION I BRAILLESKRIFT Ulipristal Acetate Gedeon Richter
INFORMATION IN BRAILLE Ulipristal Acetate Gedeon Richter
NAVN PÅ INDEHAVEREN AF MARKEDSFØRINGSTILLADELSEN Gedeon Richter
NAME OF THE MARKETING AUTHORISATION HOLDER Gedeon Richter
Efter administration af den moderate CYP3A4-hæmmer erythromycinpropionat (500 mg to gange dagligt i 9 dage) til raske kvindelige forsøgspersoner steg Cmax og AUC for ulipristalacetat henholdsvis 1,2 og 2,9 gange.
Following administration of the moderate CYP3A4 inhibitor erythromycin propionate (500 mg twice daily for 9 days) to healthy female volunteers, Cmax and AUC of ulipristal acetate increased 1.2 and
Ulipristal Acetate Gedeon Richter er kontraindiceret hos patienter med leversygdom (se pkt.
Ulipristal Acetate Gedeon Richter is contraindicated in patients with hepatic disorder (see section 4.3 and 4.4).
AUC for ulipristalacetats aktive metabolit steg 1,5 gange, mens Cmax for den aktive metabolit faldt (ændring på 0,52 gange).
2.9 fold, respectively; the AUC of the active metabolite of ulipristal acetate increased 1.5 fold while the Cmax of the active metabolite decreased (0.52 fold change).
Ulipristal Acetate Gedeon Richter indeholder: - Aktivt stof: Ulipristalacetat.
What Ulipristal Acetate Gedeon Richter contains - The active substance is ulipristal acetate.
Hvis der under gentaget intermitterende behandling efter den første reduktion i blødning eller amenorré forekommer et ændret vedvarende eller uventet blødningsmønster, f.eks. blødning mellem menstruationer, kan en undersøgelse af endometriet, inkl.
If, during repeated intermittent treatment, after the initial reduction in bleeding or amenorrhea, an altered persistent or unexpected bleeding pattern occurs, such as inter-menstrual bleeding, investigation of the endometrium including endometrial biopsy should be performed in order to exclude other underlying conditions, including endometrial malignancy.
DATO FOR ÆNDRING AF TEKSTEN DD/MM/ÅÅÅÅ
DD/MM/YYYY
Indehaveren af markedsføringstilladelsen skal i forbindelse med lanceringen og derefter sikre, at alle ordinerende læger og patologer, der ser på prøver fra patienter, som behandles med Ulipristal Acetate
The MAH shall ensure that, at launch and thereafter, all prescribers of Ulipristal Acetate Gedeon Richter and pathologists who review samples from Ulipristal Acetate Gedeon Richter-treated patients, as well as patients treated with Ulipristal Acetate Gedeon Richter, are provided with educational material.
Ulipristalacetat virker direkte på endometriet.
Mechanism of action Ulipristal acetate exerts a direct effect on the endometrium.
DATO FOR FØRSTE MARKEDSFØRINGSTILLADELSE/FORNYELSE AF TILLADELSEN
DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION Date of first authorisation: DD month YYYY Date of latest renewal: DD month YYYY
BLODPRØVE (2- 4 uger efter afslutning af Ulipristal Acetate Gedeon Richter-behandling)
2nd TEST (4 weeks after starting treatment) 3rd TEST (8 weeks after starting treatment) 4th TEST (12 weeks after starting treatment) 5th TEST (2- 4 weeks after stopping Ulipristal Acetate Gedeon Richter treatment)
DET SKAL DU VIDE, FØR DU BEGYNDER AT TAGE ULIPRISTAL ACETATE GEDEON RICHTER
What you need to know before you take Ulipristal Acetate Gedeon Richter
Ulipristal Acetate Gedeon Richter kan forårsage let svimmelhed (se pkt.
Ulipristal Acetate Gedeon Richter may cause mild dizziness (see section 4 “Possible side effects”).
ULIPRISTAL ACETATE GEDEON RICHTER 5mg TABLETTER PATIENTKORT
ULIPRISTAL ACETATE GEDEON RICHTER 5 mg TABLETS PATIENT CARD
• Informationsmateriale til ordinerende læger (gynækologer), der indeholder: o Følgeskrivelse o Produktresumé o Lægevejledning vedr.
• Educational material for prescribers (gynaecologists) which contains: o Cover letter o SmPC o Physician's guide to prescribing Ulipristal Acetate Gedeon Richter
Sådan skal du tage Ulipristal Acetate Gedeon Richter
How to take Ulipristal Acetate Gedeon Richter
LÆGEMIDLETS NAVN Ulipristal Acetate Gedeon Richter 5 mg tabletter
NAME OF THE MEDICINAL PRODUCT Ulipristal Acetate Gedeon Richter 5 mg tablets
Ulipristal Acetate Gedeon Richter 5 mg tabletter Ulipristalacetat
Ulipristal Acetate Gedeon Richter 5 mg tablets Ulipristal acetate
ordinering af Ulipristal Acetate Gedeon Richter
How to store Ulipristal Acetate Gedeon Richter
10 mg/da g N=132
10 mg/day N=132
Fortæl det til din læge, hvis du ved, at du har problemer med leveren, eller hvis du er i tvivl om, hvordan din lever har det.
Do not take Ulipristal Acetate Gedeon Richter if you have liver problems.Tell your doctor if you know that you have problems with your liver or if you have any doubts about the condition of your liver.
Brug af Ulipristal Acetate Gedeon Richter sammen med mad og drikke Du skal undgå at drikke grapefrugtjuice, når du tager Ulipristal Acetate Gedeon Richter.
You should avoid drinking grapefruit juice while on treatment with Ulipristal Acetate Gedeon Richter.
Mikrokrystallinsk cellulose Mannitol
Musculoskeletal and connective tissue disorders
LÆGEMIDLETS NAVN Ulipristal Acetate Gedeon Richter 5 mg tabletter Ulipristalacetat
NAME OF THE MEDICINAL PRODUCT Ulipristal Acetate Gedeon Richter 5 mg tablets Ulipristal acetate
Det skal du vide, før du begynder at tage Ulipristal Acetate Gedeon Richter Sådan skal du tage Ulipristal Acetate Gedeon Richter Bivirkninger
What Ulipristal Acetate Gedeon Richter is and what it is used for What you need to know before you take Ulipristal Acetate Gedeon Richter How to take Ulipristal Acetate Gedeon Richter Possible side effects